InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Brady Todd C, 董事长兼首席执行官. Director active across 3 companies, notably Aldeyra Therapeutics, Inc.. Cumulatively, 8 filings have been logged. Split: 2 buys · 1 sell. Total volume traded: €710k. Activity tracked since 30 March 2022. The latest transaction was disclosed on 3 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Brady Todd C is Président-Directeur Général and is associated with Aldeyra Therapeutics, Inc., Evoke Pharma Inc and F-star Therapeutics, Inc. He has 8 filings in total, and across the sampled recent filings between 2022-04-01 and 2026-06-05, the buy and sell amounts are EUR 416888 and EUR 292902.